+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665871
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Epigenetics Market grew from USD 3.71 billion in 2023 to USD 4.10 billion in 2024. It is expected to continue growing at a CAGR of 10.82%, reaching USD 7.63 billion by 2030.

It examines the chemical modifications that occur on DNA and histone proteins, which can affect gene expression without changing the underlying genetic code. These epigenetic changes can be influenced by several factors, including age, environment, and disease state, and they are reversible mechanisms passed down to subsequent generations. Epigenetics provides an additional layer of complexity to the regulation of gene expression, and it has significant implications for our understanding of genetics, development, and inheritance. Applications of epigenetics span from biomedical research to therapeutic interventions. In research, epigenetics offers insights into developmental biology and the etiology of diseases. Clinically, it has implications in cancer treatment, metabolic disorders, and personalized medicine. The primary end-users include academic & research institutes, pharmaceutical & biotech companies, and diagnostic centers. The need for epigenetics is increasing due to substantial growth in the prevalence of chronic and genetic disorders worldwide, favorable governmental initiatives and investments in drug discovery and development, and a growing inclination toward personalized medicines. However, the market faces certain challenges, including the high cost of developing epigenetics technologies, lack of awareness, and limited application of epigenetics, hindering the adoption of epigenetics. Ongoing research and development activities for the advancement of epigenetics and expanding the application of epigenetics in non-oncology fields present potential opportunities for the development of epigenetics.

Regional Insights

The epigenetics market in North America has exhibited substantial growth, primarily driven by the United States, attributed to heavy investments in research and development, the robust presence of pharmaceutical and biotechnology companies, and a high incidence rate of chronic diseases such as cancer. In South America, the adoption of epigenetics is in the nascent stage and has a potential for development due to the increasing prevalence of genetic disorders and cancers, and Brazil supports the development of epigenetics with an evolving healthcare sector and growing public awareness about advanced treatments. The APAC region is undergoing a rapid transition in the epigenetics sector due to emerging economies such as China, Japan, and India. China has witnessed a surge in patent filings, indicating strong governmental and private interest in epigenetics. The Japanese government encourages precision medicine, resulting in increased funding for epigenetic research programs. India's participation in epigenetic research is expanding, with an increasing number of collaborations and studies. Europe's epigenetics market is robust, led by countries such as Germany, the UK, and France. Extensive research activities, well-established healthcare systems, and growing investments from the private and public sectors propel the regional development. Additionally, active collaborations between key players and academic institutions support the development of advanced epigenetic therapies. The Middle East region is experiencing gradual progress in epigenetics due to the rising prevalence of conditions such as cancer and the expansion of healthcare infrastructure. The interest in personalized medicine is steadily gaining traction, influencing purchasing patterns. In Africa, the development of epigenetics is in the early stages, with limited research facilities. However, there is potential for expansion with increasing international collaboration in healthcare research.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Epigenetics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Significant growth in the prevalence of chronic and genetic disorders worldwide
  • Favorable governmental initiatives and investments in drug discovery and development
  • Growing inclination toward personalized medicines

Market Restraints

  • High cost of development of epigenetics technologies

Market Opportunities

  • Ongoing research and development activities for the advancement of epigenetics
  • Expanding the application of epigenetics in non-oncology fields

Market Challenges

  • Lack of awareness and limited application of epigenetics

Market Segmentation Analysis

  • Product: Increasing usage of reagents & kits for epigenetic research
  • Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
  • Methods: Rising utilization of DNA methylation for X-chromosome inactivation
  • Application: Increasing application of epigenetic tools in oncology
  • End-User: Growing need for epigenetic tools from academic & research institutes

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Epigenetics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Epigenetics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Zenith and Cencora Partner to Expedite ZEN-3694 Programme

Zenith Epigenetics partnered with Cencora to accelerate the market introduction of their cutting-edge ZEN-3694 program, aimed at revolutionizing cancer by potentiating existing therapies through epigenetic mechanisms. This collaboration is anticipated to pave the treatment for tailored development strategies, including comprehensive patient access and adherence initiatives tailored to the healthcare ecosystem.

FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research

FOXO Technologies has joined forces with DataRobot, leveraging artificial intelligence (AI) to pioneer research in epigenetic biomarkers. The union marries DataRobot's trailblazing AI with FOXO's DNA methylation microarray technology to dissect over 860,000 genomic sites, paving the way for significant strides in health and wellness.

Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry

Zymo Research Corporation formed a strategic alliance with Opentrons Labworks, Inc. to set a new standard in cell-free DNA (cfDNA) isolation and analysis. This partnership promised a groundbreaking, fully automated workflow, from sample collection to library preparation, poised to transform the field of liquid biopsy analysis.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Epigenetics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Active Motif, Inc., Agilent Technologies, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., BioCat GmbH by AddLife AB, Bioneer Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Cambridge Epigenetix Ltd., Chroma Medicine, Inc., Creative Biogene, Creative Diagnostics, Cusabio Technology LLC, Diagenode S.A. by Hologic, Inc., Elysium Health, Inc., EpiCypher, Inc., Epigenic Therapeutics, EpiGentek Group Inc., Eurofins Scientific SE, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fios Genomics Ltd., FOXO Technologies Inc., GenomeScan, GenScript Biotech Corporation, Gilead Sciences, Inc., Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Ipsen, Lonza Group Ltd., Merck KGaA, MorphoSys AG, New England Biolabs, Inc., Novogene Co, Ltd., Omega Therapeutics, Inc., Pacific Biosciences of California, Inc, PerkinElmer, Inc., Promega Corporation, ProteoGenix SAS, Qiagen N.V., Sound Agriculture Company, STORM Therapeutics LTD, Takara Holdings Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Watchmaker Genomics, Inc., Zenith Epigenetics Ltd., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product- Enzymes

  • DNA-Modifying Enzymes
  • Protein-Modifying Enzymes
  • Instruments & Accessories

Reagents & Kits

  • 5-hmC & 5-mC Analysis Kit
  • Antibodies
  • Bisulfite Conversion Kits
  • ChiP-seq Kits
  • Histones
  • Whole Genome Amplification Kits
  • Service
  • Software

Technique

  • Mass Spectrometry
  • Next-Generation Sequencing
  • Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
  • Sonication

Methods

  • DNA Methylation
  • Histone Modifications

Application

  • Cardiovascular Diseases
  • Developmental Biology
  • Immunology
  • Metabolic Diseases
  • Oncology

End User

  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
5.1.1.3. Growing inclination toward personalized medicines
5.1.2. Restraints
5.1.2.1. High cost of development of epigenetics technologies
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
5.1.3.2. Expanding the application of epigenetics in non-oncology fields
5.1.4. Challenges
5.1.4.1. Lack of awareness and limited application of epigenetics
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
5.2.4. Application: Increasing application of epigenetic tools in oncology
5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
5.3. Market Trend Analysis
5.3.1. Continuous epigenetics research for clinical and agricultural applications and technological advancements with a presence of major players in the Americas region
5.3.2. Increasing research and development activities coupled with growing geriatric population in the APAC region
5.3.3. Advanced healthcare infrastructure and strong epigenetics research activities associated with environment and agricultural applications in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Epigenetics Market, by Product
6.1. Introduction
6.2. Enzymes
6.3. Instruments & Accessories
6.4. Reagents & Kits
6.5. Service
6.6. Software
7. Epigenetics Market, by Technique
7.1. Introduction
7.2. Mass Spectrometry
7.3. Next-Generation Sequencing
7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
7.5. Sonication
8. Epigenetics Market, by Methods
8.1. Introduction
8.2. DNA Methylation
8.3. Histone Modifications
9. Epigenetics Market, by Application
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Developmental Biology
9.4. Immunology
9.5. Metabolic Diseases
9.6. Oncology
10. Epigenetics Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Epigenetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Epigenetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Epigenetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
14.3.7. Biomodal Releases Genetics And Epigenetics Solution
14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EPIGENETICS MARKET DYNAMICS
FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 119. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 122. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 123. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 124. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 125. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 126. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 127. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 128. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 129. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 132. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 133. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 136. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 137. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 138. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 139. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 140. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 141. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 142. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 143. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 146. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 155. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 156. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 157. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 172. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 176. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 183. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 184. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 185. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 186. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 187. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 188. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 189. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 196. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 197. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 198. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 199. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 200. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 201. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 202. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 203. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 206. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 207. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 210. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 211. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 212. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 213. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 214. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 215. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 216. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 217. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 220. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 225. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 226. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 227. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 228. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 229. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 230. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 231. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 234. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 235. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 238. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 239. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 240. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 241. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 242. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 243. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 244. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 245. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 248. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 253. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 254. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 255. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 256. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 257. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 258. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 259. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 262. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 267. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 268. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 269. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 270. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 271. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 272. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 273. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 276. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 281. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 282. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 283. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 284. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 285. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 286. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 287. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 290. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 295. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 296. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 297. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 298. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 299. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 300. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 301. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 304. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 309. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 310. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 311. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 312. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 313. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 314. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 315. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 318. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 319. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 322. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 323. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 324. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 325. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 326. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 327. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 328. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 329. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 332. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 333. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 336. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 337. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 338. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 339. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 340. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 341. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 342. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 343. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 344. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 345. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 346. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 355. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 356. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 357. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 360. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 361. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 362. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 363. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 364. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 365. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 366. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABLE 367. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 368. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 369. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 370. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 371. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
TABLE 372. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
TABLE 373. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 374. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 375. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 376. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 377. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 378. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 379. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
TABLE 380. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
TABL

Companies Mentioned

  • Abcam PLC
  • Abnova Corporation
  • Active Motif, Inc.
  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • BioCat GmbH by AddLife AB
  • Bioneer Corporation
  • BPS Bioscience, Inc.
  • Bristol-Myers Squibb Company
  • Cambridge Epigenetix Ltd.
  • Chroma Medicine, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • Cusabio Technology LLC
  • Diagenode S.A. by Hologic, Inc.
  • Elysium Health, Inc.
  • EpiCypher, Inc.
  • Epigenic Therapeutics
  • EpiGentek Group Inc.
  • Eurofins Scientific SE
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fios Genomics Ltd.
  • FOXO Technologies Inc.
  • GenomeScan
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Ipsen
  • Lonza Group Ltd.
  • Merck KGaA
  • MorphoSys AG
  • New England Biolabs, Inc.
  • Novogene Co, Ltd.
  • Omega Therapeutics, Inc.
  • Pacific Biosciences of California, Inc
  • PerkinElmer, Inc.
  • Promega Corporation
  • ProteoGenix SAS
  • Qiagen N.V.
  • Sound Agriculture Company
  • STORM Therapeutics LTD
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Watchmaker Genomics, Inc.
  • Zenith Epigenetics Ltd.
  • Zymo Research Corporation

Methodology

Loading
LOADING...

Table Information